Outcomes of Advanta V12 Covered Stents After Fenestrated Endovascular Aneurysm Repair.

Claire van der RietRichte C L SchuurmannEric L G VerhoevenClark J ZeebregtsIgnace F J TielliuReinoud P H BokkersAthanasios KatsargyrisJean-Paul P M de Vries

Published in: Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists (2021)

The Advanta V12 BECS used as bridging stent in FEVAR showed low complication and reintervention rates at 3 years. A substantial number of FEVAR patients required a reintervention, but most were not BECS related.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
adipose tissue
metabolic syndrome
skeletal muscle